Laws · federal-legislation

Senate Proposals Target D.C. Cannabis Sales and Driver Testing

Two Senate cannabis proposals reportedly touch D.C. retail sales and transportation drug testing, but the signal supplies no bill numbers, sponsors or text.

By Niko Adamou, Hemp & THCA ReporterPublished November 21, 20263 min read
Close-up view of the iconic United States Capitol dome with American flag in Washington, D.C.

Close-up view of the iconic United States Capitol dome with American flag in Washington, D.C.

Senate cannabis proposals covering D.C. retail sales and transportation drug testing surfaced Nov. 21, per a Cannabis Aficionado report. Bill numbers and sponsors weren't available at publication. The testing language could hinge on how THC is measured, with consequences for hemp consumers.

What the signal confirms so far

Cannabis Aficionado reported Nov. 21, 2026 on Senate proposals addressing D.C. cannabis sales and transportation testing. That's the extent of what the available signal establishes.

The feed entry carries a headline, a date and a publisher name. No bill numbers, sponsors, committee assignments or statutory text. We're not going to guess at them.

Why D.C. sales keep returning to Congress

D.C. retail cannabis sales have been shaped for years by appropriations riders, not by the District's own rulemaking. Congress controls the District's budget, so spending language can freeze or unlock what regulators there are allowed to do.

Any Senate proposal on D.C. sales matters beyond the District, because it tests whether Congress will keep using spending bills to veto local cannabis policy. For full background, see the CannIntel topic hub on D.C. cannabis sales and appropriations riders.

The transportation testing question

Transportation testing is where cannabis policy collides with chemistry. Federal drug testing for safety-sensitive transportation workers screens for marijuana metabolites. Those tests can't distinguish hemp-derived products from marijuana.

Would the Senate language change testing standards, add roadside impairment research, or do something else entirely? The signal doesn't say. Until the text is public, that stays unknown.

The delta-9 versus total THC problem

Any testing provision lives or dies on whether it measures delta-9 THC alone or total THC. THCA converts to delta-9 THC through decarboxylation when heated, so a lab method that counts only pre-heat delta-9 reads far lower than one that applies the conversion.

Metabolite urine screens sidestep the argument entirely. They flag use, not the legal status of the source product, and a hemp-compliant flower and a dispensary product can produce the same result.

What operators and drivers should watch

The operational exposure falls on D.C. retailers, hemp sellers and commercial drivers. Retailers need to know whether sales authority changes. Hemp sellers need to know whether testing language touches the total-THC definition. Drivers in safety-sensitive jobs already face zero-tolerance rules.

That's a lot of open questions for one headline. We'll update once the bill text is available.

What's unsettled

Nothing here is final, and enforcement on any resulting rules would likely vary. Proposals can be amended, stripped from larger packages or dropped. It's unsettled, and if anything advances, expect enforcement to differ by agency and jurisdiction.

Watch for three things next: published bill text, a named sponsor, and whether the language rides on a must-pass spending vehicle.

Sources

D.C. cannabis salesappropriations riderstransportation drug testingfederal cannabis legislationtotal THCTHCA
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Laws

More from the newsroom